Screener
Ionis Pharmaceuticals IONS Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Ionis Pharmaceuticals’s reported figures.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
FAQ
- What is Ionis Pharmaceuticals's invested capital?
- Ionis Pharmaceuticals (IONS) reported invested capital of $352.15M in Q2 2026.
- How has Ionis Pharmaceuticals's invested capital changed year-over-year?
- Ionis Pharmaceuticals's invested capital decreased by 68.8% year-over-year, from $1.13B to $352.15M.
- What is the long-term trend for Ionis Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's invested capital has grown at a 25.9% compound annual growth rate (CAGR), from $816.14M to $2.58B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Ionis Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude